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Abstract  29 
Aims: To compare the impact of cognitive behavioural therapy (CBT) with non-30 
directive counselling (NDC) on glycaemic control and psychological well-being in 31 
adolescents with type 1 diabetes (T1DM). 32 
Methods: Participants aged 11-16 year olds with T1DM (duration 1 year) from 4 33 
UK based paediatric diabetes centres were randomised to receive either 6 weekly 34 
sessions of one-to-one CBT (n=43) or NDC (n=42), with 2 further sessions at 6 and 35 
12 months.  Follow-up continued for 12 months post intervention.  Outcome measures 36 
included glycated haemoglobin A1c (HbA1c) and psychological scores.  37 
Results: HbA1c levels were available in 33 patients in each group for analysis.  38 
Between group difference of the overall changes in HbA1c across the study period 39 
was statically significant (p=0.018). Geometric mean (range) HbA1c in the NDC 40 
group deteriorated from 68 (46-113) to 78 (48-128) mmol/mol, i.e. [8.4 (6.4 to 12.5) 41 
to 9.3 (6.5 to 13.9) %] (p=0.001), but was maintained in the CBT group from 72 (46-42 
129) to 73(51-128) mmol/mol (p=0.51) i.e. [8.7 (6.4-14) to 8.9 (6.8-13.9)%]. More 43 
patients who have undergone CBT showed an improved or maintained HbA1c levels 44 
at 24 months (62.5 vs 35.5%, p=0.032).  Patients offered CBT with depressive scores 45 
in the lowest tertile (least depressive symptoms) showed improvement in HbA1c over 46 
time from 70 (46-102) to  67(57-87) mmol/mol (p=0.041), i.e [8.6 (6.4-11.5) to 8.3 47 
(7.4-10.1)%], but not in the NDC group.  CBT showed borderline improvements in 48 
Children’s Health Locus of Control (internal) scores over time compared with NDC 49 
(p=0.05).  The Self-efficacy score showed significantly improvement in both CBT 50 
(p<0.001) and NDC (p=0.03) groups over time.  51 
Conclusions: CBT demonstrated better maintenance of glycaemic control 52 
compared with NDC.  53 
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Introduction 54 
Type 1 diabetes mellitus (T1DM) is one of the most common chronic health 55 
condition affecting children and adolescents.  Long term prospective data have 56 
shown that intensive diabetes management in patients with T1DM is effective in 57 
reducing the development of long term complications and preventing early 58 
mortality (1)(2).  However, optimal glycaemic control is challenging to achieve 59 
and highly dependent on the patient’s adherence to lifelong daily multiple self-60 
management tasks. Glycaemic control deteriorates in patients T1DM during 61 
adolescence (3,4) due to a combination of physiological, psychological and social 62 
factors (5). Adherence is a major challenge, particularly in patients with  negative 63 
self-perceptions, who perceive little internal control over health and have an 64 
external attributional style for negative life events (6).  Conversely, adolescents 65 
may be more likely to comply with interventions they believe to be effective (7), 66 
and whilst there is good evidence that parental involvement can improve 67 
adherence (8), this must be balanced against the need to achieve autonomy.  68 
Furthermore, psychiatric morbidity, ranging from major depressive, conduct, and 69 
generalised anxiety disorders (9), to milder symptomatology (10) has been 70 
described in T1DM and may impact on metabolic control (11–14).  71 
In the U.K, psychological care is part of the multi-disciplinary care in all children 72 
and adolescents with diabetes under national guidelines (15). Individual 73 
randomised controlled trials in the past have suggested that psychological 74 
treatment may help to improve glycaemic control in children and adolescents with 75 
T1DM, but the overall evidence remained weak (16).  In addition, there is a lack 76 
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of research comparing the efficacy of different types of psychological 77 
interventions offered to children and adolescents with T1DM.  78 
Cognitive behavioural therapy (CBT) has been shown to be effective in a range of 79 
paediatric conditions compared with standard care (17), and reported as one of the 80 
most commonly used psychological intervention in children with T1DM (16). It is 81 
a structured time-limited, problem-orientated therapy based on the notion that a 82 
person’s reaction to an event are largely determined by the meaning attached to 83 
the event rather than the event itself  (18).  84 
In this study, we hypothesised that CBT improves glycaemic control and 85 
psychological well-being by addressing cognitions leading to negative attitudes 86 
and behaviours associated with sub-optimal diabetes self-management. The 87 
primary aim of the study was to compare the impact of CBT and non-directive 88 
supportive counselling (NDC) on glycaemic control in adolescents diagnosed with 89 
T1DM. The secondary aim was to investigate changes in the psychological well-90 
being in the participants treated with CBT vs NDC.  91 
 92 
Methods  93 
Study Design 94 
This was a multi-centred, randomized controlled trial (NCT00360061) with 12-95 
month post-intervention follow-up. Participants were randomised to CBT or NDC 96 
with stratification by gender and centre according to the minimization method (19) 97 
after a 3-month run-in period, with baseline dietetic education (3-day food diary 98 
and a home visit from a dietician) to compensate for potential variations in the 99 
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dietetic provision between participating centres. The participant’s diabetes team 100 
was blinded as to the outcome of randomisation. Ethical approval for the study has 101 
been granted by the multi-centre research ethics committee (MREC 01/5/34) and 102 
participating hospitals in the South West of England. 103 
Participants 104 
Children and adolescents, aged 11-16 years, diagnosed with T1DM for over 12 105 
months from 4 paediatric diabetes centres in South-West England, UK (Bristol 106 
Royal hospital for Children, Southmead Hospital, Gloucester General Hospital 107 
and the Royal Devon and Exeter Hospital) were approached by their diabetes 108 
team. Exclusion criteria included other serious chronic illnesses, special 109 
educational needs or residential care.  As specified by the Ethical Committee, any 110 
participant identified as having a significant psychiatric or child safe guarding 111 
issue subsequent to recruitment, would be referred to the appropriate clinical team 112 
for further management and withdrawn from the study. Written informed consent 113 
from the carers and assent from the participant were obtained by the study 114 
coordinator.  Standard multi-disciplinary diabetes management continued during 115 
the study.   116 
Interventions 117 
CBT was provided by a qualified CBT therapist and consisted of 6 one-to-one weekly 118 
sessions with single follow-up sessions at 6 and 12 months located according to the 119 
participant’s choice, either in the primary care surgery or hospital out-patient 120 
department or participant’s home.  A specific CBT package was developed according 121 
to Beck’s methodology (16) aiming to empower adolescents to develop and/or 122 
maintain appropriate attitudes to their diabetes, optimising diabetes self-care and 123 
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glycaemic control. Patients were given information sheets, homework assignments to 124 
complete at home that are discussed during the sessions.  In summary, the programme 125 
addresses: 1) Developing and maintaining a therapeutic relationship. 2) Cognitive 126 
restructuring: identifying negative automatic thoughts, recognising associations 127 
between thoughts, feelings and behaviour and replacing with more balanced thoughts. 128 
3) Problem solving (20), assertiveness training (21), relaxation. The therapist received 129 
weekly supervisions from a Consultant Clinical Psychologist (British Association of 130 
Behavioural and Cognitive Psychotherapies) who also reviewed a sample of audio-131 
taped therapy sessions, to ensure faithfulness to the model.  132 
NDC was provided by an experienced trained counsellor and was delivered to the 133 
same timetable as the CBT and was supervised by a Child and Adolescent 134 
Psychiatrist.  Supportive counselling was client centred, non-directive, and 135 
provided time for the young person to express any issues/concerns.   136 
Outcome measures 137 
All participants had the following outcome measures:  138 
1. Demographical and clinical data including baseline age, gender, age at 139 
diagnosis, number of years since diagnosis, age at recruitment, insulin dosage, 140 
diabetic complications, other medical conditions, family history of diabetes 141 
and Townsend deprivation index derived from participants’ postcodes (22,23). 142 
2. Glycaemic control assessed by capillary HbA1c samples obtained at 143 
recruitment (t=-3 months), end of run-in phase i.e. after the dietetic 144 
intervention and prior to the start of therapy (t=0 months), and 3, 9, 15 and 24 145 
months calculated relative to the start of therapy. A single centralised DCCT 146 
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aligned laboratory by high performance liquid chromatography (COBAS® 147 
analyser, Roche Professional Diagnostics’ Products, West Sussex, UK) was 148 
used.  149 
3. Psychological measures by self-reported questionnaires at initiation (t=0 150 
months) and 3 and 24 months of CBT or NDC including (see table 1 for 151 
reliability and validity): 152 
a. Parcel-Meyer Children’s Health Locus of Control (LOC) (24) assess the 153 
degree to which an individual believes their health is dependent on their own 154 
behaviour (internal), or is determined by others (powerful others), or to be a 155 
result of chance factors (chance). Subjects are asked to indicate “yes” or “not” 156 
to 20 statements about sources of health item and scored a point each. Higher 157 
scores represent higher locus of control in each subscale. 158 
b. Well-being Questionnaire (WBQ) by Bradley et al (25) is a 22-item, multi-159 
dimensional measure that assesses depression (6 items), anxiety (6 items), 160 
energy (4 items) and positive well-being (6 items). Each item is scored from a 161 
4 point Likert scale from 0 to 3 indicating “not at all” to “all the time”, and 162 
summed according to formulae.  A higher score indicates more of the mood 163 
described by the subscale. A total well-being score is obtained by summing all 164 
scores of the subscales after reversing the anxiety and depressing scores.   165 
c. Self-efficacy for Diabetes Scale by Grossman et al (26) evaluates adolescents 166 
perception of their ability and power in diabetes and related situation. Subjects 167 
are asked to rate their degree of confidence for 35 items with a 6-point Likert  168 
=“very sure I can”.  6= “very sure I can’t” to  1scale from  Higher scores 169 
indicate greater diabetes self-efficacy.  170 
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d. Diabetes’ Quality of Life for Youths (DQOL) (27) assess patients’ perception 171 
of the impact of an intensified regime on the general satisfaction with life and 172 
on concerns over social and vocational issues related to diabetes. This is a 173 
questionnaire with 24, 11 and 17 statements scoring the patient’s perceived 174 
disease impact, disease related worries and diabetes life satisfaction 175 
respectively.  The items are scored on a 6 point Likert scale from 0= “never” 176 
to 5 = “all the time” or 0 = “very unsatisfied” to 5= “very satisfied”. Higher 177 
scores indicate higher quality of life. 178 
e. Diabetes Family Behaviour Scale (DFBS) (28): measures diabetes-specific 179 
family support. The scale can also be sub-analysed in 2 subscales to reflect 180 
guidance-control and warmth-caring. This is a 47 item questionnaire scoring 181 
on a 5 point Likert scale 1= “all the time” to 5= “never”. A lower final score 182 
indicates greater family involvement. 183 
Statistical analysis 184 
Power calculation based on HbA1c mean [Standard Deviation (SD)] of 185 
8.84(1.39)%  [73.1 (15.3) mmol/mol] in 11-16 year olds (n=133) with diabetes 186 
diagnosed >1 year at the lead site indicated 31 subjects per group were required to 187 
give a 80% probability of detecting a 1% (11 mmol/mol) difference in mean 188 
HbA1c between two groups at 5% significance.  189 
Demographical characteristics classed as continuous variables were compared by 190 
the 2-sided student t-test, while categorical data by the Chi-square or Fisher’s 191 
exact tests as appropriate.  HbA1c and psychology scores were analysed by 192 
repeated measures ANOVA using a compound symmetry model which uses all 193 
available results and accommodate subjects with missing data.  The factors of 194 
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interest were the differences in longitudinal changes over time both between (as 195 
indicated by group x time interaction) and within groups. HbA1c results were 196 
positively skewed and logarithmically transformed prior to statistical analysis and 197 
reported in geometric means (ranges) in NGSP(%)  and IFCC units (mmol/mol). 198 
Psychological scores were normally distributed and reported in mean and standard 199 
error (SE) HbA1c were compared at t=0, 3, 9, 15 and 24 months and psychology 200 
scores at t=0, 3 and 24 months where t=0 denoted the beginning of the 201 
intervention. Statistical significance was assumed at p-values of <0.05. Statistical 202 
software IBM SPSS for Windows version 23 (released 2015, Armonk, NY: IBM 203 
Corp) was used.  204 
Results 205 
Subjects and recruitment 206 
The identification and recruitment process is summarised in figure 1. Out of 302 207 
patients from all participating clinics, 87 eligible patients fulfilled the inclusion 208 
criteria and agreed to take part, but 2 withdrew and were excluded in the run-in phase. 209 
Having completed the run-in phase, 85 patients were randomised to CBT (n=43) and 210 
NDC (n=42). However, 19 participants disengaged from the study and never started 211 
the intervention. They were equally represented in the CBT (n=10/43) and NDC 212 
(n=9/42) groups with no differences compared with the remaining participants with 213 
respect to gender (Males: 47% vs M 44%) and family history of diabetes (25% vs 214 
18%), but were slightly older mean age (SD) at diagnosis of diabetes: [9.2(3.6) vs 215 
7.6(3.5) years] and recruitment to the study [14.3(1.5) vs 13.8(1.5)years].  The HbA1c 216 
at recruitment (t=-3 months) were significantly higher in the omitted cases than the 217 
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remainder [geometric mean (range) 77(55-134) vs 73(44-132) mmol/mol, p=0.043], 218 
[i.e. 9.2(7.2-14.4) vs 8.8(6.2-14.2)%].  219 
The ‘intention-to-treat’ HbA1c analysis reported was based on 66 (CBT n=33; NDC 220 
n=33) participants who have taken part in the study (figure 1). During the study, 3 221 
patients from the CBT group subsequently withdrew with non-attendance of 222 
intervention (n=1) and need for further psychological interventions (n=2).  Two 223 
participants in the NDC group withdrew: one cited time constraints (n=1) and the 224 
other refused further sessions (n=1).  In all 30 in the CBT and 31 in the NDC group 225 
completed the study.  226 
Demographic data 227 
There were no group differences in demographic characteristics, prevalence of 228 
diabetes complication, number of other medical conditions, family history of diabetes 229 
and presence of both parents at home (table 2). All patients in both groups of this 230 
study were on subcutaneous insulin injections. Dietetic home visits were completed 231 
within a mean (SD) of 3.8 (2.2) months.  232 
Changes in Glycaemic control 233 
HbA1c were positively skewed and log transformed before comparison. Within group 234 
comparison showed that mean log HbA1c increased significantly with time in the 235 
NDC (p=0.001), but remained unchanged in the CBT (p=0.51) group (table 3). 236 
Between group difference of the overall changes in HbA1c across the study period 237 
was statically significant (p=0.018). The number of participants who showed an 238 
improved or maintained HbA1c levels at 24 months was significantly greater in the 239 
CBT compared with the NDC group (62.5 vs 35.5%, p=0.032).    240 
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Psychological outcomes 241 
Psychological scores of the 33 subjects in each group included in the analysis are 242 
shown in table 4. The Self-efficacy score showed significant improvement in both the 243 
CBT (p<0.001) and NDC (p= 0.03) groups over time, but there were no between 244 
group differences (p=0.93). 245 
 246 
The internal LOC score showed a borderline increase over time in the CBT (p=0.05), 247 
no changes in the NDC group, and significant differences over time between the 2 248 
groups (p=0.041). There were no within or between group differences in the other 249 
LOC subscales. There is a trend, however, towards lowering the LOC (powerful 250 
others) and LOC (chance) in the NDC group, but not the CBT group (the differences 251 
are not statistically significant). 252 
 253 
There were no statistically significant between group differences in the WBQ total or 254 
sub-scores. However, there was a statistically significant reduction of WBQ 255 
(depression) scores in the NDC group (p=0.019) and a non-significant reduction in the 256 
WBQ (anxiety) scores in the NDC group. Sub-analysis of subjects with WBQ 257 
depression scores in the lowest tertile (least depressed) demonstrated significant 258 
reduction in HbA1c over time in the CBT group (p=0.041), no within group changes 259 
in the NDC group, and significant between group differences over time (p=0.008). 260 
(table 3) 261 
 262 
 263 
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Discussion  264 
The outcomes of our study have shown that a short course of CBT over a 12-month 265 
period prevented deterioration of glycaemic control in adolescents with T1DM, whilst 266 
an increase in HbA1c overtime was observed in participant who underwent NDC 267 
mirroring the pattern observed in clinical practice and population based studies (3,4). 268 
Stabilisation of HbA1c is important as the Diabetes Control and Complication Trial 269 
(DCCT)(1)(2) identified that all improvements in HbA1c are beneficial, even in 270 
adolescence, in delaying the onset or slowing the progression of diabetic 271 
complications.  The prevention of HbA1c deterioration in this study is a clinically 272 
significant result in itself, and further studies are warranted to investigate if an 273 
improvement following CBT may be associated with the increased length of 274 
intervention, follow up and /or sample size, or inclusion of patient psychological 275 
characteristics and symptoms.  276 
Outcomes of the psychological assessments demonstrated improvements in some but 277 
not all areas over time in one or both groups. In particular, CBT showed an 278 
improvement in the Internal Locus of Control score over the study period compared 279 
with NDC. This might be because CBT works on identifying and changing potentially 280 
distorted negative thoughts and unhelpful behaviours to improve patients’ feelings. 281 
An improvement in self-efficacy was seen in both CBT and NDC groups with no 282 
between group differences.  Similar findings have been shown in  adults with T1DM 283 
offered CBT compared with blood glucose awareness training (29). However, the 284 
increase in self-efficacy scores may merely be a reflection of improved self-285 
confidence as the patients gain experiences in their diabetes self-management over 286 
time that is independent of the psychological therapy offered.  287 
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Our results showed an improvement in depression scores over time in the NDC group, 288 
but this may be due to the lower baseline score at the beginning of the intervention. 289 
The other reasons for the observed differences could be in the nature of the 290 
interventions. Namely, the NDC is by itself less-directive, less goal-oriented in itself 291 
more supportive and exerts less pressure and expectations on the patients. This could 292 
be also supported by the trend towards the reduction of WBQ anxiety scores observed 293 
in the NDC. However, the lack of group differences over time means NDC was no 294 
more effective than CBT in this aspect of well-being. 295 
Interestingly, sub-analysis revealed an improvement in glycaemic control over time 296 
that was only shown in the subjects with depression scores in the lowest tertile (least 297 
depressive symptoms) in the CBT group. It is possible that adolescents with more 298 
depressive symptoms are less receptive to therapy within the short time frame and/or 299 
limited number of CBT sessions offered.  A small study by McGrady et al have 300 
demonstrated improvements in depressive symptoms and diabetes management in 301 
adolescents with T1DM who have subclinical depressive symptoms after 12 sessions 302 
of CBT which was double the number of sessions offered compared with our study 303 
(30).  In addition, evidence suggested that CBT may be ineffective in severe cases of 304 
depression (31). On the other hand, these patients with more depressive symptoms 305 
according to the results may be receptive to NDC to improve these symptoms. 306 
Therefore, formal baseline assessment for depressive moods should be undertaken to 307 
stratify the appropriate type and length of psychological interventions offered to 308 
patients. 309 
In clinical practice, full formal courses of CBT or other psychological interventions 310 
are labour intensive with poor uptake in patients who are not motivated. However, it 311 
is possible to implement basic techniques of CBT in patients’ during their routine care 312 
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by other health professional in the diabetes multidisciplinary team such as nurses who 313 
have undergone recognised training. Patients, who are least adherent or with more 314 
depressive symptoms, are also less likely to participate in interventions which require 315 
a lot of self-motivation as in the case of CBT.  These patients might benefit from 316 
motivational or other techniques. Our data suggested that NDC could be considered 317 
over CBT as first line therapy in patients with more severe depressive symptoms. 318 
However, there were no differences in a number of other psychological outcomes 319 
measured despite the better glycaemic outcomes in the CBT group in our study, which 320 
was consistent with previous findings (29)(32)(33).  This indicates that the 321 
relationship between glycaemic control and psychological well-being is not straight 322 
forward. Further investigations into the influences of other factors, such as patient and 323 
carers’ differences in learning style, degree of engagement, cognitive ability, and 324 
family functioning with therapy are needed.  325 
The main strength of this study was its multi-centred design with the inclusion of 326 
patients from different paediatric diabetes centres of varied socio-economic 327 
backgrounds, so the results are more widely generalisable. However, there were some 328 
limitations in our study.  Only 41% of the eligible patients approached agreed to 329 
participate in this study. Time constraints were an issue for many, while others did not 330 
feel the need for professional psychological interventions. The difficulties inherent in 331 
engaging an adolescent population in psychological interventions is not unique to our 332 
study. Despite this, the intention-to-treat HbA1c analysis has reached the expected 333 
numbers as per power calculation. Although there were a small number of drop-outs 334 
and missing data during the intervention period, our statistical analysis has employed 335 
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models which taken into account any potential bias among the participants and 336 
missing data points.  337 
In conclusion, a short course of CBT offered to children and adolescents newly 338 
diagnosed with T1DM prevented the deterioration in glycaemic control which is 339 
otherwise observed. Greater improvement in glycaemic control was demonstrated in 340 
those offered CBT who were less depressed at the start of therapy. Subjects who had 341 
CBT showed greater belief that health is controlled by their own will. Both CBT and 342 
NDC may improve the self-efficacy in diabetes management. Further research is 343 
needed to explore which treatment indications, including patient characteristics, are 344 
most likely to improve clinical and cost effectiveness of psychological interventions 345 
in children and young people with T1DM.  346 
 347 
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Table 1: Reliability and Validity of psychological scores 459 
 460 
Psychology Score 
 
Reliability  
 
Validity 
 
Self-efficacy (26) Kuder-Richardson coefficient  
0.90 
 
Against locus of control 
r=0.42, p<0.001 
Against self-esteem  
r=0.41 p<0.001 
Against average bloods 
glucose value  r=0.27, p<0.05 
Childhood Health Locus of 
control (24) 
   Overall  
     
 
Kuder-Richardson coefficient  
 
0.753 
Against “standard” (Nowicki-
Strickland Children’s locus of 
control) r=0.501 (p<0.004) 
 
Well-being (25) 
    Depression  
    Anxiety 
    Energy 
    Positive Well-being 
    Total 
 
Cronbach’s alpha coefficient 
 
0.68 
0.74 
0.64 
0.80 
Against  patient rated diabetes 
poorly controlled r=0.23 
p<0.01 (depression), r=0.21, 
p<0.01 (anxiety), no 
correlation with HbA1c  
Diabetes Quality of life 
measures (27) 
    Satisfaction 
    Impact 
    Worries 
Cronbach’s alpha coefficient 
 
0.85 
0.83 
0.82 
Against predictor of self-rated 
health status  
r= 0.42, p<0.01 
r=-0.45, p<0.001 
r=-0.45, p<0.001 
Diabetes Family Behaviour 
Scale (28) 
    Total 
    Guidance-control 
    Warmth-caring 
 
Cronbach’s alpha coefficient 
 
0.86 
0.81 
0.79 
Against HbA1c  
 
r=-0.12, p<0.03 
r=-0.17, p<0.002 
r=-0.06, p<0.29 
 461 
 462 
 463 
 464 
 465 
 466 
 467 
 468 
 469 
 470 
 471 
 472 
 473 
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Table 2: Demographic and clinical characteristics of the Cognitive Behavioural 474 
Therapy (CBT) and Non-directive Counselling (NDC) Groups 475 
 476 
 CBT 
 
NDC p 
N 43 
 
42  
Gender:       Male  44% 45% 0.92 
Age at diagnosis of diabetes                                                   
Median (range) years 
8.4 (1.5-14.1) 8.2 (1.6-14.4) 0.92 
Age at recruitment                                    
Median (range) years 
13.2 (11.4-17.0) 14.1 (11.7-16.6) 0.10 
 
Duration of diabetes at recruitment                                             
Median (range) years 
4.6 (1.2 - 14.5) 5.7 (1.6 - 12.9) 0.56 
 
Insulin dose per kg                  
Mean (SD) 
1.26 (0.39) 1.25 (0.39); n=40) 0.84 
 
Diabetes Complications:  
Background retinopathy 
Other 
 
1 (n=41) 
0 (n=41) 
 
2 (n=37) 
0 (n=37) 
 
0.60 
0.95 
Other medical conditions 
(e.g. asthma, hayfever, eczema, 
hypothyroidism) 
12 12 0.95 
Parent or sibling with diabetes 6 (n=41) 
 
10 0.29 
Sibling in the study 3 
 
3 >0.99 
Both natural parents in participant’s 
home 
25 (n=38) 25 (n=40) 0.76 
Townsend Deprivation Score* 
                        Median(range) 
-1.94 (-4.15 - 5.04) -1.62(-3.74 - 4.71) 0.79 
 
 477 
*Census output is Crown copyright and is reproduced with the permission of the Controller of 478 
HMSO and the Queen's Printer for Scotland. 479 
Where data are missing, the number of cases analysed are stated in parentheses. 480 
 481 
 482 
 483 
 484 
 485 
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Table 3: Summary statistics of the HbA1c values (in % and mmol/mol)  for the CBT and NDC groups, at 0, 3, 9, 15 and 24 months.   
 
 Between group differences Within group 
differences 
Intervention 
 
total  
n 
Comparison 
 
Baseline 
 
3 months 
 
9 months 
 
15 months 
 
24 months 
 
ANOVA 
 
CBT 
 
33 
 
Geometric mean 
(range) 
 
8.7 (6.4-14) 
72 (46-130) 
 
9.0 (6.8-12.8) 
75 (51-116) 
 
8.7 (6.0-11.8) 
72 (42-105) 
 
8.7 (6.4-12.2) 
72(46-110) 
 
8.9 (6.8-13.9) 
74 (51-128) 
 
0.51 
 
NDC 
 
33 
 
Geometric mean 
(range) 
 
8.4 (6.4-12.5) 
68 (46-113) 
 
8.6 (6.2-12.2) 
70 (44-110) 
 
8.9 (7.0-13.4) 
74 (53-123) 
 
9.0 (6.2-13.3) 
75 (44-122) 
 
9.4 (6.5-13.9) 
79 (48-128) 
 
0.001 
 
  
Intervention x time 
     
0.018 
  
CBT * 
 
11 
 
Geometric mean 
(range) 
 
8.6 (6.4-11.5) 
70 (46-102) 
 
9.2 (7.1-12.8) 
77 (54-116) 
 
8.2 (6.6-11.7)  
66 (49-104) 
 
8.0 (6.9-9.4) 
64 (52-79) 
 
8.3 (7.4-10.1)  
67 (57-87) 
 
0.041 
 
NDC* 
 
11 
 
Geometric mean 
(range) 
 
8.5 (7.0-12.4) 
69 (53-112) 
 
8.7 (7.1-12.2) 
72 (54-110) 
 
8.9 (7.6-13) 
74 (60-119) 
 
9.3 (7.0-10.7) 
78 (53-93) 
 
10.0 (6.5-14.2) 
86 (48-132) 
 
0.12 
 
  
 
Intervention x time 
     
0.008 
  
* patients in the lower tertile of depression scores  
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Table 4: Outcomes of psychological interventions 
 
 Between group differences Within group 
differences 
Score 
 
Intervention 
 
total  
n 
Comparison 
 
Baselines 
 
3 months 
 
24 months 
 
ANOVA 
 
Self-efficacy CBT 33 Mean (SE) 158.5 (4.0) 166.2 (4.2) 172.4 (4.2) <0.001 
  NDC  33 Mean (SE) 157.9 (4.2) 165.6 (4.3) 170.0 (4.7) 0.003 
  
 
  Intervention x time 
  
0.92   
LOC CBT 33 Mean (SE) 5.3 (0.15) 5.7 (0.17) 5.7 (0.17) 0.05 
 (internal) NDC  33 Mean (SE) 5.6 (0.13) 5.5 (0.14) 5.3 (0.16) 0.42 
  
 
  Intervention x time 
  
0.04   
LOC CBT 33 Mean (SE) 1.3 (0.26) 1.1 (0.29) 1.2 (0.29) 0.79 
 (powerful others) NDC  33 Mean (SE) 1.6 (0.23) 1.4 (0.25) 1.0 (0.29) 0.20 
  
 
  Intervention x time 
  
0.52   
LOC CBT 33 Mean (SE) 2.5 (0.22) 2.3 (0.24) 2.5 (0.24) 0.57 
 (chance) NDC  33 Mean (SE) 2.4 (0.21) 2.3 (0.22) 1.9 (0.25) 0.12 
  
 
  Intervention x time 
  
0.21   
WBQ CBT 33 Mean (SE) 5.5 (0.57) 4.9 (0.61) 5.4 (0.60) 0.41 
 (depression) NDC  33 Mean (SE) 6.3 (0.48) 5.1 (0.49) 5.4 (0.57) 0.019 
     Intervention x time   0.47   
WBQ CBT 33 Mean (SE) 4.7 (0.55) 4.6 (0.59) 5.0 (0.58) 0.75 
 (anxiety) NDC  33 Mean (SE) 5.9 (0.52) 5.0 (0.55) 4.8 (0.67) 0.21 
     Intervention x time   0.30   
WBQ CBT 33 Mean (SE) 7.5 (0.44) 7.6 (0.49) 6.7 (0.48) 0.17 
 (energy) NDC  33 Mean (SE) 7.1 (0.34) 7.5 (0.36) 7.3 (0.44) 0.55 
     Intervention x time   0.39   
  
22 
 
WBQ CBT 33 Mean (SE) 11.8 (0.61) 12.45 (0.65) 11.67 (0.64) 0.29 
 (positive) NDC 33 Mean (SE) 11.24(0.57) 12.2 (0.59) 11.2 (0.69) 0.14 
     Intervention x time   0.61   
WBQ CBT 33 Mean (SE) 45.1 (1.9) 46.34 (2.0) 44.0 (2.0) 0.26 
 (total) NDC 33 Mean (SE) 42.1 (1.6) 45.7 (1.7) 44.1 (2.0) 0.06 
  
 
  Intervention x time 
  
0.24   
DQOL CBT 33 Mean (SE) 56.0 (2.3) 57.1 (2.5) 54.2 (2.4) 0.51 
 (disease impact) NDC  33 Mean (SE) 55.0. (2.1) 57.6 (2.2) 56.2 (2.6) 0.55 
  
 
  Intervention x time 
  
0.73   
DQOL CBT 33 Mean (SE) 20.3 (1.3) 21.5 (1.4) 20.5 (1.4) 0.65 
 (disease related  NDC 33 Mean (SE) 22.3 (1.7) 25.5 (1.8) 22.4 (2.2) 0.35 
 worries) 
 
  Intervention x time 
  
0.65   
DQOL CBT 33 Mean (SE) 64.2 (2.5) 63.8 (2.6) 64.5 (2.6) 0.93 
(diabetes  life NDC 33 Mean (SE) 62.3 (2.4) 66.0 (2.5) 60.8 (3.0) 0.30 
satisfaction) 
 
  Intervention x time 
  
0.31   
DFBS CBT 33 Mean (SE) 42.5 (2.0) 39.4 (2.3) 36.3 (2.2) 0.16 
 (guide & control) NDC 33 Mean (SE) 38.3 (1.5) 35.8 (1.5) 36.1 (1.8) 0.23 
  
 
  Intervention x time 
  
0.54   
DFBS CBT 33 Mean (SE) 49.3 (1.9) 47.1 (2.1) 46.4 (2.1) 0.50 
 (warmth & caring) NDC 33 Mean (SE) 46.9 (1.2) 46.2 (1.3) 46.4 (1.5) 0.89 
  
 
  Intervention x time 
  
0.68   
DFBS CBT 33 Mean (SE) 146.9 (5.2) 139.0 (5.9) 134.9 (5.7) 0.31 
 (total) NDC  33 Mean (SE) 137.7 (3.1) 134.7 (3.3) 135.2 (3.8) 0.66 
     Intervention x time   0.52   
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Figure 1: Study Flowchart  
 
 
       
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients at participating 
clinics assessed for eligibility 
(n=302)  
 
• Not eligible and excluded (n=18)  
• Declined  
- No reasons given (n=132)  
- Lack of time & commitments (n=69)  
Lost during intervention (n=3): 
- Non-attendance to CBT (n=1)  
- Referrals to child and  
  adolescent mental health   
  services (n=2)  
 
Patient withdrawal (n=2): 
- Time constrain (n=1) 
- Refused therapy (n=1)  
 
Randomisation 
Agreed to take part 
(n=87)  
Patient changed their minds about 
taking part and withdrew (n=2) 
CBT (n=43) 
 
HbA1c Intention 
to treat analysis 
(n=33) 
 
Never attended interventions and 
absent HbA1c levels (n=10) 
 
Completion 
 of study  
(n=30) 
NDC (n=42) 
Completion  
of study  
(n=31) 
HbA1c Intention 
to treat analysis 
(n=33) 
 
Never attended interventions 
and absent HbA1c levels 
(n=9) 
 
